Home › NDC Lookup › RxCUI directory › RxCUI 312242

Paroxetine hydrochloride 2 MG/ML Oral Suspension — RxCUI 312242

RxNorm drug concept · Semantic clinical drug
RxCUI 312242 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI312242
Official nameParoxetine hydrochloride 2 MG/ML Oral Suspension
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asparoxetine (as paroxetine hydrochloride) 10 MG per 5 ML Oral Suspension; PARoxetine HCl 10 MG in 5 mL Oral Suspension
FDA products mapped2
Package NDCs mapped2
Reported Medicaid activity (SDUD)2,086 prescriptions · 25 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Paroxetine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It usually takes a few weeks before you notice the full benefit — that's completely normal for this type of medication. Some people notice small improvements in sleep or energy wit...
  • How long before I start feeling better on paroxetine?
  • Please don't stop suddenly — paroxetine is one of the antidepressants most likely to cause discontinuation symptoms if you quit cold turkey. These can include dizziness, nausea, ir...
  • Can I just stop taking paroxetine if I feel better or if it bothers me?
📖 Read our full Paroxetine guide →

🕸️ Concept Web — How Paroxetine hydrochloride 2 MG/ML Oral Suspension Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Paroxetine hydrochloride 2 MG/ML Oral Suspension RxCUI 312242

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Paroxetine 32937
    • Paroxetine hydrochloride 235830
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Paxil 114228
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Paroxetine Oral Suspension 373245
    • Paroxetine hydrochloride Oral Suspension 2648367
    • Paroxetine Oral Liquid Product 1164136
    • Paroxetine Oral Product 1164137
    • Paroxetine hydrochloride Oral Liquid Product 2661250
    • Paroxetine hydrochloride Oral Product 2662815
    • Paroxetine Oral Suspension [Paxil] 366082
    • Paroxetine hydrochloride Oral Suspension [Paxil] 2656595
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Paroxetine hydrochloride 2 MG/ML 1738490
    • Paroxetine hydrochloride 2 MG/ML Oral Suspension [Paxil] 213291
    • Paroxetine hydrochloride 2 MG/ML [Paxil] 1738492

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Paroxetine hydrochloride 2 MG/ML SCDC · 1738490
  • Paroxetine Oral Suspension SCDF · 373245
  • Paroxetine hydrochloride Oral Suspension SCDFP · 2648367
  • Paroxetine Oral Liquid Product SCDG · 1164136
  • Paroxetine Oral Product SCDG · 1164137
  • Paroxetine hydrochloride Oral Liquid Product SCDGP · 2661250
  • Paroxetine hydrochloride Oral Product SCDGP · 2662815

Brand-Name Concepts

  • Paroxetine hydrochloride 2 MG/ML Oral Suspension [Paxil] SBD · 213291
  • Paroxetine hydrochloride 2 MG/ML [Paxil] SBDC · 1738492
  • Paroxetine Oral Suspension [Paxil] SBDF · 366082
  • Paroxetine hydrochloride Oral Suspension [Paxil] SBDFP · 2656595
  • Paxil Oral Liquid Product SBDG · 1182920
  • Paxil Oral Product SBDG · 1182921
  • Paxil BN · 114228

📦 FDA Products & Package NDCs

2 products · 2 package NDCs
2 package NDCs map to RxCUI 312242 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
31722-0578-25 1 BOTTLE in 1 CARTON (31722-578-25) / 250 mL in 1 BOTTLE PAROXETINE HYDROCHLORIDE Camber Pharmaceuticals, Inc. 2026-03-05
70954-0319-10 250 mL in 1 BOTTLE (70954-319-10) Paroxetine ANI Pharmaceuticals, Inc. 2021-09-03
Observed labelers: ANI Pharmaceuticals, Inc. (1) · Camber Pharmaceuticals, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.